$SPTX 4 SEC Filings

Filed On	Filing
24 Jun 2026	Form 4: Hombach Robert J., Director Bought 13,000 shares ($236K)
06 May 2026	Form 4: PureTech Health plc, 10% owner and 1 other Received 16,382,534 shares by conversion
04 May 2026	Form 4: Zohar Daphne, Director Granted 1,758,599 Stock Option (Right to Buy)
04 May 2026	Form 4: Healy James, Director Received 2,731,538 shares by conversion
04 May 2026	Form 4: White Lauren, Chief Financial Officer Granted 63,680 Stock Option (Right to Buy) · Received 6,702 shares by conversion
04 May 2026	Form 4: Wheadon David E., Director Granted 12,258 Stock Option (Right to Buy)
04 May 2026	Form 4: Peterson Sandra E, Director Granted 12,258 Stock Option (Right to Buy)
04 May 2026	Form 4: Gladstein Lana, General Counsel Granted 63,680 Stock Option (Right to Buy) · Received 33,515 shares by conversion
04 May 2026	Form 4: Chen Michael Cunyuan, Chief Scientific Officer Granted 63,680 Stock Option (Right to Buy) · Received 3,351 shares by conversion
04 May 2026	Form 4: Torres Denice, Director Granted 12,258 Stock Option (Right to Buy) · Received 13,406 shares by conversion
04 May 2026	Form 4: Paul Steven M, Director Granted 1,003,450 Stock Option (Right to Buy) · Received 67,031 shares by conversion
04 May 2026	Form 4: Arch Venture Partners XII, Llc, 10% owner and 6 others Received 5,194,951 shares by conversion · Bought 1,100,000 shares ($19.8M)
04 May 2026	Form 4: Hombach Robert J., Director Granted 12,258 Stock Option (Right to Buy)
04 May 2026	Form 4: Loebel Antony, Chief Medical Officer Granted 63,680 Stock Option (Right to Buy) · Received 20,109 shares by conversion
04 May 2026	Form 4: Mates Sharon, Director Granted 49,033 Stock Option (Right to Buy)

Comments